During the past few years, nanoparticles have been increasingly present in our everyday lives. To gain a better understanding of their health impacts, several studies have focused on the effects they have on our bodies and cells.
“Because of their small size, nanoparticles can cross different physiological barriers – such as that which separates the brain from the bloodstream (blood-brain barrier), the skin or the placenta that protects a foetus – and thus spread throughout the body,” explains Aurélie Niaudet, chemical engineer in the Risk Assessment Department at the French Agency for Food, Environmental and Occupational Health and Safety (ANSES), which in 2020 published a report on nanomaterials in foods.
Nanosynth Group plc (LON:NNN) nano-technology business that originated in Nottingham from a partnership with Nottingham Trent University. Their core mission is to develop unique ways to produce and apply nanoparticles.